Healthcare & Life Sciences
Resproly
China
Resproly is a Healthcare & Life Sciences startup based in China, most recent round Series C+, 1 tracked investor.
unknownseries-c-plus
series-c-plus
Stage
1
Investors
About Resproly
Resproly is a startup based in China. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Resproly is a Chinese medical technology company focused on the development and commercialization of innovative medical devices and drugs for respiratory diseases.
Explore Resproly's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.